Subscribe to RSS

DOI: 10.1055/s-0045-1806872
Papilledema as a Marker for Predicting Outcomes in Patients with Moderate Head Injury
Authors
Funding None.

Abstract
Introduction Papilledema indicates raised intracranial pressure, which is a significant finding in head injury patients. Being a bedside marker, papilledema can be used for predicting the prognosis in head trauma patients.
Objective The aim of the study was to assess papilledema as a single prognostic marker in moderate head injury adult patients.
Materials and Methods An observational study was done at the Sawai Man Singh Medical College on 120 patients with moderate head injury (Glasgow Coma Scale [GCS] score of 9–12). CT scan and fundoscopy were done in all patients within the first 24 hours and then the patients were followed up for 3 days. Outcomes were noted in terms of Glasgow Outcome Scale (GOS) during a follow-up of 72 hours after admission where a GOS score of 5 was defined as good outcome.
Results Papilledema was present in 25 (20.83%) patients, with early papilledema (<24 hours) in 1 (4.00%) patient and delayed papilledema (up to 72 hours) in 24 (96.00%) patients. Common CT findings were contusions (61.67%), subarachnoid hemorrhage (30.83%), and diffuse axonal injury (2.5%). The GCS score was 9 in 45 (37.50%) patients, 10 in 31 (25.83%) patients, 11 in 30 (25.00%) patients, and 12 in 14 (11.67%) patients at admission. Compared with those without papilledema, patients with papilledema had significantly more contusions (84 vs. 55.79%, p = 0.031). There was a significant association of GCS at 24 hours with papilledema (p < 0.05). Even GOS score showed a significant association with papilledema (p < 0.0001). The absence of papilledema demonstrated sensitivity of 96.87% (95% confidence interval [CI]: 89.16–99.62%) and specificity of 41.07% (95% CI: 28.10–55.02%) with an area under the curve of 0.69 (95% CI: 0.60–0.77) for predicting good outcomes.
Conclusion Papilledema was present in 25 (20.83%) cases of moderate head injury. The absence of papilledema showed 70.83% predictability for good outcomes, showing a significant association with prognostication of patients allowing its usage for monitoring and management of the patients.
Publication History
Article published online:
21 April 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Zhong H, Feng Y, Shen J. et al. Global burden of traumatic brain injury in 204 countries and territories from 1990 to 2021. Am J Prev Med 2025; (e-pub ahead of print)
- 2 Rauchman SH, Albert J, Pinkhasov A, Reiss AB. Mild-to-moderate traumatic brain injury: a review with focus on the visual system. Neurol Int 2022; 14 (02) 453-470
- 3 Mattar AB, Sabry A, Saleh S. Papilloedema as a single prognostic factor in moderate head injured adult patients. Interdiscip Neurosurg 2020; 21: 100699
- 4 Lee AG, Wall M. Papilledema: are we any nearer to a consensus on pathogenesis and treatment?. Curr Neurol Neurosci Rep 2012; 12 (03) 334-339
- 5 Rigi M, Almarzouqi SJ, Morgan ML, Lee AG. Papilledema: epidemiology, etiology, and clinical management. Eye Brain 2015; 7: 47-57
- 6 Joshua SP, Agrawal D, Sharma BS, Mahapatra AK. Papilloedema as a non-invasive marker for raised intra-cranial pressure following decompressive craniectomy for severe head injury. Clin Neurol Neurosurg 2011; 113 (08) 635-638
- 7 Fitzgerald M, Tan T, Rosenfeld JV. et al. An initial Glasgow Coma Scale score of 8 or less does not define severe brain injury. Emerg Med Australas 2022; 34 (03) 459-461
- 8 Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1 (7905) 480-484
- 9 Wilson L, Boase K, Nelson LD. et al. A manual for the Glasgow Outcome Scale-Extended interview. J Neurotrauma 2021; 38 (17) 2435-2446
- 10 Parsons JH. The Pathology of the Eye. New York, NY: GP Putnam's Sons; 1908
- 11 Selhorst JB, Gudeman SK, Butterworth IV JF, Harbison JW, Miller JD, Becker DP. Papilledema after acute head injury. Neurosurgery 1985; 16 (03) 357-363
- 12 Kulkarni AR, Aggarwal SP, Kulkarni RR, Deshpande MD, Walimbe PB, Labhsetwar AS. Ocular manifestations of head injury: a clinical study. Eye (Lond) 2005; 19 (12) 1257-1263
- 13 Lafta G, Sbahi H. Factors associated with the severity of traumatic brain injury. Med Pharm Rep 2023; 96 (01) 58-64
- 14 Goel A, Bansal A, Rawat K. Head injury patients at a tertiary health care center. Int Surg J 2022; 9: 1706-1709
- 15 Kafle P, Khanal B, Yadav DK, Poudel D, Karki T, Cherian I. Head injury in Nepal: an institutional based prospective study on clinical profile, management and early outcome of traumatic brain injury in Eastern Part of Nepal. Birat J Health Sci 2019; 4 (02) 750-754
- 16 Alberts A, Lucke-Wold B. Updates on improving imaging modalities for traumatic brain injury. J Integr Neurosci 2023; 22 (06) 142